Table-I: Represents demographics and biochemical parameters of T1DM, T2DM
and control subjects.
Approximately 24 million T2DM
patients in Europe are likely to develop diabetic kidney disease (DKD),2 which is projected to rise in line with the increasing prevalence of diabetes.
Approximately 24 m T2DM
patients in Europe are likely to develop diabetic kidney disease,2 which is projected to rise in line with the increasing prevalence of diabetes.
Eun-Ok Im, Ph.D., from Duke University in Durham, North Carolina, and colleagues used data from 164 participants of two larger internet survey studies (62 women diagnosed with T2DM
and 102 women without diabetes) to evaluate associations between T2DM
and sleep-related symptoms among midlife women.
JPAD 2 was the first-ever study to evaluate the long-term efficacy of low-dose aspirin for prevention of dementia specifically in patients with T2DM
, a known risk factor for dementia.
 HbA1c of 7% is the suggested glycaemic target for T2DM
24 SGLT-2 inhibitors have been used in both the initiation and intensification of therapy of T2DM
. The approved drugs in this class include dapagliflozin (2012), canagliflozin (2013), empagliflozin (2014), and ertugliflozin (2017).
(2,3) The treatment of T2DM
is generally multimodal in order to target the various mechanisms that cause hyperglycemia.
Recent studies have shown the positive effects of bariatric surgery procedures in the treatment of obese and non-obese patients with T2DM
. Therefore, bariatric surgery is also referred to as metabolic surgery due to its effects ranging from weight loss to metabolic control, especially in patients with T2DM
This study stresses on the collaborative work to manage T2DM
especially in patients with uncontrolled blood sugar.
Exercise is considered as the main building block of T2DM
The medications, which include sitagliptin (Januvia) and linagliptin (Tradjenta), are used to treat patients with T2DM
who are inadequately controlled by first-line treatments.